Tag: our research
-
ACT NOW study update
We hear from two clinical psychologists who are helping young people after their brain tumour treatments through our ACT NOW study.
-
Announcing funding of pioneering glioblastoma research
The Brian Cross Memorial Trust will fund ‘Future Leader’ Dr Spencer Watson’s three year glioblastoma brain tumour research.
-
Nine brain tumour centres awarded Centre of Excellence status
New ‘Tessa Jowell Centre of Excellence’ status recognises delivery of outstanding care and treatment by NHS staff in their efforts to provide above excellent patient care through a difficult time
-
Developments in cannabis-based drug trial for glioblastomas
The Brain Tumour Charity responds to trial suggesting cannabis-based drug could be combined with chemotherapy in recurrent glioblastomas
-
Research at risk
We are calling on the Prime Minister to protect charity funded research – and we need your help!
-
The Brain Tumour Charity announces a ground-breaking research partnership
The Oli Hilsdon Foundation pledges £1.5 million to fund a pioneering University College London research programme into brain tumours.
-
Our founders win global recognition for charity achievement
Neil and Angela Dickson have been named as the first recipients of a major global award from world leaders in the field.
-
Promising developments for paediatric low grade glioma drug
Our researchers from The Everest Centre have new results that show the drug trametinib can stop tumour growth in some children with low grade brain tumours, in some cases the tumour was seen to shrink as well.
-
Celebrities unite to back our Great Minds t-shirt campaign
Across the board, support for our awareness and fundraising campaign is gathering pace
-
The Brain Tumour Charity responds to the news of Tom Parker’s glioblastoma diagnosis
There was a huge outpouring of support for Tom Parker and his family, following his announcement across social media platforms on Monday of his brain tumour diagnosis.
-
Nobel Prize-winning technique used in research into brain tumours
The Nobel Prize for Chemistry 2020 has just been awarded to two female scientists, Emmanuelle Charpentier and Jennifer Doudna, for their work on developing the CRISPR/Cas9 gene editing technique.
-
The impact a gift can make
Back in 2015 we launched our five year strategy ‘Defeating Brain Tumours’ and our research strategy ‘A Cure Can’t Wait’. Our manifestos were unashamedly ambitious, but we knew they had to be.
-
Shining a light on the differences between glioblastoma cells
A new publication from one of our research projects shines a light on the differences between the cells in the middle/core of a glioblastoma (GBM) compared to the cells spreading/infiltrating into healthy brain around the tumour.
-
Picking up the pace of meningioma research
Dr Gelareh Zadeh is leading research in Canada which will help predict the risk of meningioma regrowth.
-
Announcing our new multi-million pound investment into research
Many things are uncertain right now, but our commitment to research isn’t one of them.
-
Improving patient experience is our priority
The recent National Cancer Patient Experience Survey highlighted, once again, that those diagnosed with a brain tumour have one of the worst experiences of all cancer patients.
-
Grandmother’s petition for research reaches milestone 100,000
Fiona started the petition to call the Government to tackle hard to treat childhood cancers after her grandson died from a brain tumour.
-
Our free research webinars bring the research community together in lockdown.
The Brain Tumour Charity is curating and facilitating a series of 60-minute webinars for researchers. The webinars feature experts in the brain tumour field speaking on a wide range of current topics.
-
Focused ultrasound shows early promise in glioblastoma brain tumours
Researchers are pioneering a promising use of focused ultrasound against glioblastoma, an aggressive brain tumour.
-
Researchers develop a new ‘liquid biopsy’ blood test to accurately diagnose certain types of primary brain tumour
Researchers have developed a new ‘liquid biopsy’ blood test to diagnose brain tumours, which could reduce the need for invasive procedures.
-
Researchers identify genes that can drive development of brain tumours
The human genome contains nearly 22,000 genes and various studies have explored the nearly 2% of DNA that creates proteins. Far less is known about the remaining 98% of DNA that does not encode protein.
-
Artificial Intelligence improves Brain tumour diagnosis
A new machine learning approach can classify gliomas, a common type of brain tumour, into low or high grades with almost 98% accuracy, researchers report in the journal IEEE Access.
-
Australia to begin ground-breaking trial in children with brain cancer
Australia is joining the clinical trial to test a new treatment in children with brain cancer. The trial will be led by Sydney Children’s Hospital.
-
More than two million in backlog for cancer care
Around 2.4 million people in the UK are waiting for cancer screening, tests or treatment because of disruptions to the NHS, according to new analysis by Cancer Research UK.